Exhibit 99.1
Paul Broyer
Candela Corporation
508-358-7400 x435
CANDELA REPORTS SECOND FISCAL QUARTER EARNINGS
Wayland, MA — January 23, 2007 — Candela Corporation (NASDAQ: CLZR) announced today that revenues for its second fiscal quarter, ended December 30, 2006, were $37.4 million versus $37.7 million for the same quarter a year earlier. For the six-month period ended December 30, 2006, revenues were $70.9 million versus $65.8 million for the same period a year earlier.
Net income for the quarter was $1.0 million or $0.04 cents per share versus $4.5 million or $0.19 cents per share for the same quarter a year earlier. For the six-month period, the Company reported net income of $5.4 million or $0.23 cents per share versus $7.5 million or $0.32 cents per share for the same period last year.
Gerard E. Puorro, Candela’s President and Chief Executive Officer, said: “These results did not meet any of our expectations. The revenue shortfall forces us to recalibrate those expectations. We previously felt a 15% to 18% growth at the top line for the fiscal year was achievable. That clearly is no longer the case, and now appears to be more in the 7% to 9% range.” Puorro continued: “As previously stated, and as evidenced by our increased R&D spending, we have begun to launch a series of new products that will be on display at the upcoming 65th Annual American Academy of Dermatology Conference in Washington, D.C. on February 3-5, 2007.” Puorro added: “We obviously need to closely monitor the acceptance of these products for the remainder of our fiscal year to see if they are getting sufficient traction to get us back on a growth track more suitable to this industry and these markets.”
About CANDELA: Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 18 years ago, and currently has an installed base of 10,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com.
Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela’s current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, the risk of an
adverse judgment in the patent litigation with Palomar Medical Technologies, Inc., (PMTI), dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela’s performance is included in Candela’s periodic reports filed with the SEC, including but not limited to, Candela’s Annual Report on Form 10-K for the year ended July 1, 2006, and subsequent Quarterly Reports on Form 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela’s expectations or any change in events, conditions or circumstances on which any such statement is based.
